Vous avez cherché: haemodynamic (Anglais - Maltais)

haemodynamic endpoints
punti finali emodinamiċi

penile erection is a haemodynamic process.
l-erezzjoni tal-pene hija proċess emodinamiku.

systemic haemodynamic parameters and ecgs were also evaluated.
il-parametri emodinamiċi sistemiċi u l-ecgs ġew evalwati wkoll.

haemodynamic parameters were not assessed in these studies.
ma kienux assessjati parametri emodinamiċi f' dawn l- istudji.

respiratory and haemodynamic symptoms should be treated symptomatically.
sintomi respiratorji u emodinamiċi għandhom jiġu kkurati b'mod sintomatiku.

particular attention should be paid to maintaining haemodynamic status.
għandha tingħata attenzjoni partikulari sabiex jinżamm l-istat ħemodinamiku.

invasive haemodynamic parameters were assessed in the first study only.
il-parametri emodinamiċi invażivi kienu evalwati fl-ewwel studju biss.

these findings were in accordance with improvements in additional haemodynamic parameters.
dawn ir-riżultati kienu konformi ma’ titjib fil-parametri emodinamiċi addizzjonali.

invasive haemodynamic parameters were assessed at baseline and after 12 weeks treatment.
il-parametri invasivi emodinamiċi kienu mkejla fil-linja bażi u wara 12-il ġimgħa ta’ kura.

no clinically important pulmonary haemodynamic, systemic haemodynamic, or ecg changes were observed.
ebda tibdil emodinamiku pulmonari, emodinamiku sistemiku jew fl-ecg klinikament importanti ma ġie osservat.

these haemodynamic improvements from baseline were similar with or without co-administration of epoprostenol.
dan it-titjib emodinamiku fil-parametri dinamiċi mil-linja bażi kien l-istess bl-għoti flimkien ta’ epoprotestenol jew mingħajru.

however, the pericardial effusion was clinically significant in 2 patients with some associated haemodynamic compromise.
imma, effużjoni perikardjali kienet klinkalment sinifikanti f’ 2 pazjenti b' xi kompromess emodinamiku assoċjat.

in such circumstances, nitrates should only be administered under close medical supervision with appropriate haemodynamic monitoring.
f’dawn iċ ċirkostanzi, in-nitrati għandhom biss jingħataw taħt sorveljanza medika stretta, b’sorveljanza xierqa emodinamika.

haemodynamic parameters: these were assessed in stride-1 for both functional class ii and iii patients.
parametri emodinamiċi kienu assessjati fi stride-1 fuq pazjenti kemm fi klassi funzjonali ii kif ukoll fi klassi funzjonali iii.

improvements in haemodynamic and clinical parameters have been observed in dasatinib-treated patients with pah following cessation of dasatinib therapy.
titjib fil-parametri emodinamiċi u kliniċi ġie osservat f’pazjenti kkurati b’dasatinib wara l-waqfien tal-kura b’dasatinib.

due to sevoflurane’s low solubility in blood, these haemodynamic changes may occur more rapidly than with other volatile anaesthetics.
minnħabba li sevoflurane għandu solubilità baxxa fid-demm, dawn il-bidliet emodinamiċi jistgħu jiġru aktar malajr minn loppji oħra volatili.

no clinical trial data are available comparing directly in intra-patient observations the acute haemodynamic response after intravenous to that after inhaled iloprost.
l-ebda informazzjoni minn provi kliniċi m’hi disponibbli li tqabbel direttament, permezz ta’ osservazzjonijiet fil-pazjent stess, ir-rispons emodinamiku akut wara l-għoti fil-vini ta’ iloprost ma’ dak wara li iloprost ikun meħud man-nifs.

these are patients with refractory or recurrent angina associated with dynamic st deviation, heart failure, life- threatening arrhythmias or haemodynamic instability.
dawn huma pazjenti li qegħdin ibatu minn anġina rikurrenti jew rifrattorja assoċjata ma’ devjazzjoni st dinamika, mard tal-qalb, arrhythmias li jistgħu jwasslu għal-mewt jew nuqqas ta’ stabbilità emodinamika.

in such circumstances, nitrates should still only be administered under close medical supervision with appropriate haemodynamic monitoring (see section 4.3).
f’ċirkostanzi bħal dawn, in-nitrati għandhom jingħataw biss taħt superviżjoni medika stretta b’monitoraġġ emodinamiku adegwat (ara sezzjoni 4.3).

effects observed in repeat-dose toxicity studies were mainly due to the exaggerated pharmacodynamic activity of riociguat (haemodynamic and smooth muscle relaxing effects).
l-effetti osservati fi studji dwar l-effett tossiku minn dożi ripetuti kienu primarjament minħabba l- attività farmakodinamika esaġerat ta’ riociguat (effetti emodinamiċi u rilassament tal-muskoli l-lixxi).